Viewing Study NCT05386459


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-03-05 @ 6:44 PM
Study NCT ID: NCT05386459
Status: COMPLETED
Last Update Posted: 2022-05-27
First Post: 2022-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Use of the Drug Ingaron in Patients With COVID-19
Sponsor: SPP Pharmaclon Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module